A Phase II Study of Hyperfractionated Accelerated Radiotherapy Delivered With Integrated Neck Surgery for Node-Positive Cases in Squamous Cell Carcinoma of the Head and Neck
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
John Waldron, MD
Principal Investigator
Princess Margaret Hospital, Canada
Canada: Ethics Review Committee
UHN REB 01-0557-C
NCT00188318
June 1998
Name | Location |
---|